M. Eraksoy Et Al. , "The use of IFNB-1 b therapy before and after 16 years ofage in children with multiple sclerosis: a prospective follow-up," 17th Meeting of the European-Neurological-Society , Rhodes, Greece, pp.39, 2007
Eraksoy, M. Et Al. 2007. The use of IFNB-1 b therapy before and after 16 years ofage in children with multiple sclerosis: a prospective follow-up. 17th Meeting of the European-Neurological-Society , (Rhodes, Greece), 39.
Eraksoy, M., Akinan-Demir, G., Yapici, Z., Kurtuncu, M., Mutlu, M., Topcular, B., ... Durmus, H.(2007). The use of IFNB-1 b therapy before and after 16 years ofage in children with multiple sclerosis: a prospective follow-up . 17th Meeting of the European-Neurological-Society (pp.39). Rhodes, Greece
Eraksoy, M. Et Al. "The use of IFNB-1 b therapy before and after 16 years ofage in children with multiple sclerosis: a prospective follow-up," 17th Meeting of the European-Neurological-Society, Rhodes, Greece, 2007
Eraksoy, M. Et Al. "The use of IFNB-1 b therapy before and after 16 years ofage in children with multiple sclerosis: a prospective follow-up." 17th Meeting of the European-Neurological-Society , Rhodes, Greece, pp.39, 2007
Eraksoy, M. Et Al. (2007) . "The use of IFNB-1 b therapy before and after 16 years ofage in children with multiple sclerosis: a prospective follow-up." 17th Meeting of the European-Neurological-Society , Rhodes, Greece, p.39.
@conferencepaper{conferencepaper, author={M. Eraksoy Et Al. }, title={The use of IFNB-1 b therapy before and after 16 years ofage in children with multiple sclerosis: a prospective follow-up}, congress name={17th Meeting of the European-Neurological-Society}, city={Rhodes}, country={Greece}, year={2007}, pages={39} }